Oxidative stress and free radicals in liver and kidney diseases; an updated short-review by Amiri, M
Oxidative stress and free radicals in liver and kidney diseases; 
an updated short-review
www.nephropathol.com                          DOI: 10.15171/jnp.2018.30                                J Nephropathol. 2018;7(3):127-131
Journal of  Nephropathology 
*Corresponding author: Masoud Amiri, Ph.D, Email;masoud.amiri@yahoo.com 
Masoud Amiri*
Social Determinants of  Health Research Center and Department of  Epidemiology and Biostatistics, Shahrekord University of  Medical 
Sciences, Shahrekord, Iran 
S
ho
rt
 R
ev
ie
w
ARTICLE INFO
Article type:
Short Review
Article history:
Received: 10 April 2017 
Accepted: 20 July 2017 
Published online: 18 September 2017
Keywords:
Oxidative stress,
Free radicals 
Liver diseases
Antioxidant therapy 
Chronic kidney disease 
Reactive oxygen species
Context: In normal conditions, liver and kidney act as a supply of internal antioxidants for 
neutralizing free radicals produced by viruses and internal/external compounds which 
were processed in the liver and kidney. 
Evidence Acquisition: PubMed, EBSCO, Embase, Web of Science, directory of open access 
journals (DOAJ), Scopus, and Google Scholar were searched using keywords of oxidative 
stress, free radicals, liver diseases, kidney diseases  and antioxidant therapy.
Results: When the antioxidants of the liver or kidney are low, or when the liver/kidney is 
under pressure through oxidative insults, the damages produced by free radicals would 
increase, leading to inflammation and fibrosis. In addition to cytotoxic effect of oxidative 
stress, it has also a substantial role in modulating of messengers in regulating the functions 
of cell membrane, with a vital factor for survival. However, there is also some benefits 
of oxidative stress such as inducing apoptosis to prepare birth canal for delivery or 
strengthening of biological defense mechanisms during ischemia and physical exercise. 
Conclusions: There is an important association between diseases related to lifestyle and 
oxidative stress, as a condition that oxidation may exceed the antioxidant systems of the 
body with absence of balance between them. Oxidative stress is involved with many 
diseases such as kidney, liver and lung dysfunctions. Supplementation with vitamins C and 
E and selenium for four months could improve the balance between antioxidant-oxidant 
as well as potential slowing down of liver disease progression.
ABSTRACT
Implication for health policy/practice/research/medical education:
Oxidative stress has an important effect on chronic kidney disease with a recommendation of  treatment by antioxidants.
Please cite this paper as: Amiri M. Oxidative stress and free radicals in liver and kidney diseases; an updated short-review. J 
Nephropathol. 2018;7(3):127-131. DOI: 10.15171/jnp.2018.30.
1. Context
In normal conditions, the liver and kidney act as a supply 
of  internal antioxidants for neutralizing free radicals 
produced by viruses and internal/external compounds 
which were processed in the liver and kidney (1). However, 
when the concentration of  antioxidants in liver/kidney 
are low, or when the liver or kidney are under pressure 
through oxidative insults (due to alcohol or infections of 
hepatitis B and C virus or renal tubular cell damage), the 
damage produced by free radicals would increase, leading 
to inflammation and fibrosis (2). In fact, oxidative stress 
can be defined as an imbalance between producing of 
oxidants (reactive oxygen species or free radicals) and 
their eliminating through protective mechanisms like 
antioxidants (3). In fact, when reactive forms of  oxygen 
would produce faster than they could be neutralized by 
antioxidants, resulting in oxidative stress (4). Moreover, 
increasing pro-oxidant formation, decreasing or lacking 
antioxidants may also lead to oxidative stress (5). In 
addition to the cytotoxic effect of  oxidative stress, it has 
also a substantial role in modulating of  messengers in 
regulating the functions of  cell membrane, with a vital 
factor for survival (6). However, there is also some 
benefits of  oxidative stress such as inducing apoptosis 
to prepare birth canal for delivery or strengthening of 
biological defense mechanisms during ischemia and 
physical exercise (6).
There is an important association between diseases 
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related to lifestyle and oxidative stress, as a condition 
that oxidation may exceed the antioxidant systems of 
the body with the absence of  balance between them (6). 
Lifestyle diseases, as multifactorial diseases, could have 
three important causal factors including genetic, habitual 
and environmental (6). Moreover, many associated 
genes with biological oxidative stress, many daily related 
habits leading to oxidative stress (such as smoking, 
drinking and irregular diet) and many environmental 
factors like oxygen radicals and carcinogenesis have been 
reported (6). Generally, oxidative stress can be caused by 
alcohol, drugs (anti-inflammation, anti-analgesic, anti-
cancer and antidepressants), environmental pollutants 
(mercury chloride, lead, microcystin) and other factors 
(mobile phone-like radiofrequency radiation exposure, 
temperature (cold stress), benzoyl peroxide, ZnO2, 
maternal high-fat diet and thyroid dysfunction (7). 
Moreover, alcohol consumption could be accounted 
for at least 3.8% of  world mortality (7). In addition, 
it is believed that consumption of  alcohol could have 
a positive action for oxidative stress as well as the 
promotion of  inflammatory and fibrotic damage (8). 
In fact, chronic alcohol consumption may result in 
progressive liver damage, followed by inflammation and 
production of  cytokine (9). Furthermore, it has been 
reported that antioxidant consumption could prevent the 
toxic effects of  alcohol on liver or kidney (9). Because 
of  inducing oxidative stress by alcohol, the antioxidant 
defense system would be compromised. Therefore, 
in addition to standard medical care, prescription of 
antioxidant supplements is recommended (10).
2. Evidence Acquisitions
PubMed/Medline, EBSCO, Embase Web of  Science, 
directory of  open access journals (DOAJ), Scopus, 
and Google Scholar were searched using keywords of 
oxidative stress, free radicals, liver diseases, antioxidant 
therapy, chronic kidney disease, reactive oxygen species, 
hypertension, diabetes mellitus, dyslipidemia, end-stage 
renal disease, liver dysfunction and antioxidant systems.
3. Oxidative stress
Oxidative stress is involved with many diseases including 
neurodegenerative diseases (Alzheimer’s diseases [AD], 
Parkinson’s disease [PD], amyotrophic lateral sclerosis 
[ALS], heart diseases (coronary hearth diseases [CHD], 
atherosclerosis, stroke/ischemia), obesity, kidney 
diseases (urolithiasis and diabetic nephropathy), lung 
diseases (asthma, pulmonary fibrosis and lung cancer), 
eye disease (cataract, age related macular degeneration 
[AMD], diabetic retinopathy [DR], autoimmune 
uveitis [AIU], retinitis pigmentosa [RP]), skin diseases, 
reproductive system, blood disorder (beta-thalassemia, 
acute lymphoblastic leukemia [ALL]), joint disorder 
(rheumatoid arthritis, temporomandibular [TMB] joint 
disorders, systemic lupus erythematosus [SLE]), liver and 
pancreatic diseases, diabetes, Wilson’s diseases (11) and 
brain diseases (12). 
The kidney is a susceptible organ to oxidative stress 
(13). There are many studies regarding oxidative stress 
and free radicals with kidney diseases (14). Oxidative 
stress may have an important impact on uremia, renal 
insufficiency and other kidney diseases (15). In fact, in 
the pathophysiology of  many kidney diseases and related 
complications of  these diseases, oxidative stress plays 
an important role in mediating oxidative stress alone, 
oxidative stress-related mediators and inflammation (14). 
In addition, there are many factors such as some diseases 
like hypertension, diabetes and hypercholesterolemia, 
some antibiotics, chemotherapeutics and radiocontrast 
agents, environmental toxins and occupational 
chemicals, radiation, smoking and alcohol which may 
induce oxidative stress in the kidney (14). Moreover, 
there is some evidence about the association between 
uremia (treated with hemodialysis or peritoneal dialysis) 
and enhanced oxidative stress which in turn would 
decline antioxidants levels in these patients (16,17). In 
fact, oxidative stress could play an important role in 
many renal diseases such as glomerulonephritis, acute 
or progressive renal failure, tubulointerstitial nephritis 
(18,19). In addition, the understanding sources and roles 
of  oxidative stress regarding endothelial dysfunction, 
inflammation, atherosclerosis and glomerulosclerosis 
has been highly increased in recent decades. However, 
there is still no confirmed information about the 
effects of  antioxidant therapy on hemodialysis patients, 
despite the primary benefits of  antioxidants among 
these patients (20). Moreover, there is still no accepted 
explanation about the exact role of  free radicals and 
oxidative stress in the pathogenesis of  many acute and 
chronic kidney insufficiency, nephrological diseases, 
glomerulonephritis, gentamicin nephrotoxicity and 
ischemic- reperfusion injury (21). Oxidative stress has an 
important effect on chronic kidney disease (CKD) (22) 
with a recommendation of  treatment by antioxidants 
(21). 
CKD is a worldwide health problem with increasing 
incidence (22). In addition, low concentration of 
free radicals can play a vital role in many physiologic 
functions. However, their excess concentration could 
also lead to cellular damage and pathological processes 
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such as atherosclerosis (23). Moreover, CKD patients 
may be affected by many situations such as hypertension, 
diabetes and dyslipidemia which all are associating with 
oxidative stress (22). It has been reported that using 
antioxidant-based dialysis membranes, like vitamin 
E and vitamin C modified cellulose membranes, can 
reduce oxidative stress in dialysis patients (24, 25). 
Furthermore, excess consumption of  dietary salt may 
modulate oxidative stress and target organ damage 
through angiotensin II (13). Moreover, increasing kidney 
disease and related end-stage renal disease (ESRD) 
may be associated to ageing of  population’ and high 
morbidity may be associated with lifestyle diseases like 
hypertension, diabetes and atherosclerosis (15).
There are many compounds for therapy of  CKD patients 
including L-Carnitine, vitamin E, vitamin C, coenzyme 
Q10, α-lipoic acid, selenium, green tea, resveratrol, 
curcumin and omega-3 polyunsaturated fatty acids, 
which can administer alone or as a combination (26). 
However, these positive effects have not been confirmed 
everywhere (27). 
In addition to kidney, the liver is also prone to oxidative 
stress-related damages. The liver is the principal 
organ for detoxifying of  various compounds and its 
diseases are a substantial worldwide health problem 
(5). Oxidative stress could contribute to all conditions 
of  liver dysfunction with different etiologies (28). 
Moreover, increasing oxidative stress in hepatocytes 
could indeed be one of  the substantial mechanisms of 
liver dysfunction (9). In addition, the effect of  oxidative 
stress in the pathogenesis of  liver dysfunction has been 
studied (29). Moreover, cirrhosis patients are prone to 
oxidative stress which is related to the severity of  liver 
cirrhosis (1). Although, because of  the role of  oxidative 
stress in initiating and progressing of  liver damage, 
antioxidant therapy, by using natural and synthetic 
antioxidants, is mainly applying for preventing and 
treating of  liver diseases as a potential extra-appropriate 
treatment. However, there is still a long way for applying 
antioxidants to all liver diseases (7). The exact mechanism 
of  oxidative stress on the liver dysfunction is not well 
known (30). In addition, there is enough evidence about 
the association of  oxidative stress and compromised 
antioxidant defense system (31). Measurement of 
oxidative stress could be through different methods 
such as “electron paramagnetic resonance (EPR)”, 
determination of  “peroxidation products” or “lipid 
peroxidation products” or “isoprostanes” or “protein 
carbonyl groups” or “DNA damage”, measurement of 
glutathione (GSH) and determination of  antioxidant 
enzymes or antioxidant molecules (30). Since oxidative 
stress can be considered as a pathogenetic phenomenon 
playing a substantial causal role in different liver diseases 
such as hepatitis, nonalcoholic steatohepatitis (NASH), 
fibrosis, cirrhosis and hepatitis type C. Therefore, 
monitoring endo-/exogenous enzymes and antioxidants 
to control free radicals level is very vital (30). Antioxidants 
could also be used for preventing and treating patients 
with alcoholic liver disease (ALD), nonalcoholic fatty 
liver disease (NAFLD) and other liver diseases (7).
During metabolic processes, many highly reactive 
compounds may produce named free radicals, which 
could participate in some physiological phenomena like 
immune response, inflammatory reaction and metabolism 
of  fatty acids (unsaturated) (32). Excess amounts of  free 
radicals may indeed lead to impairment of  enzymes, 
membranes and DNA and further changes in the activity 
of  immune system (29). When the generation of  free 
radicals exceeds the ability of  system for neutralizing 
and elimination them, oxidative stress may occur (33). 
In addition, the balance between antioxidants and 
free radicals is very important in many diseases (32). 
Furthermore, free radicals could result in an oxidation 
condition that may lead to injury in cellular membrane 
and related metabolic processes (34). They may also 
involve many degenerative diseases such as diabetes 
mellitus, lung and kidney damage, atherosclerosis, liver 
diseases and aging (35). Furthermore, free radicals could 
be released as a subsequence of  hepatic detoxification of 
chemicals, drugs and toxic compounds in the liver (36). 
Moreover, due to the ability of  antioxidants of  cells and 
tissues to prevent the injury produced by free radicals, 
reactions of  pathological free radicals do not necessarily 
lead to cell and tissue damage (37). In addition, due to 
very short half-lives of  free radicals, oxidative stress 
is assessed by measuring of  different stable oxidized 
productions of  modified, lipids, proteins, nucleic acids 
and carbohydrates (2). In fact, free radicals or active 
oxygen species would be abnormally or excessively 
produced, the balance between forming and removing 
would be damaged and oxidative stress will initiate (6). 
Free radicals could also have a substantial role in the 
pathogenesis of  tissue damage in many diseases such 
as kidney damage, inflammation, hepatic dysfunction 
and immune injury (38). Free radical might indeed lead 
to liver diseases which may induce by many situations 
such as alcohol abuse, fibrosis/cirrhosis of  different 
etiologies, viral hepatitis and paracetamol overdose (39). 
4. Antioxidants
Antioxidant level of  blood could not reflect only the 
organ damaged by oxidative stress, but also their level 
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changes for responding to other organs’ diseases (4). 
In fact, different antioxidants have different effects and 
their additive effect in plasma may protect against attacks 
of  free radicals (40). For instance, daily consumption of 
Rosmarinus officinalis, as an antioxidant, hepatoprotective 
substance and a free radical scavenger, could limit the 
extent of  histological damages as well as prevention of 
oxidative damage (34). In addition, supplementation with 
vitamins C and E and selenium for four months could 
improve the balance between antioxidant-oxidant as well 
as potential slowing down of  disease progression (3). On 
the other hand, decreasing of  vitamins E and C levels 
may indicate that antioxidant system breakdown might 
be the cause of  developing and progressing of  disease 
(41). In a study, antioxidant therapy (for four months) 
had a positive effect on antioxidant-oxidant balance as 
well as improving liver function test, but not reduced the 
systemic inflammation (42). 
5. Conclusions
There is an important association between diseases 
related to lifestyle and oxidative stress, as a condition that 
oxidation may exceed the antioxidant systems of  the body 
with the absence of  balance between them. Oxidative 
stress is involved in many diseases such as kidney, liver 
and lung dysfunctions. Supplementation with vitamins C 
and E and selenium for four months could improve the 
balance between antioxidant-oxidant as well as potential 
slowing down of  liver disease progression.
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